Biomatlante is a pioneering brand in the field of biologics, specializing in the development, manufacturing, and commercialization of synthetic bone graft technologies. With a strong emphasis on innovation and aggressive product development, Biomatlante is a trusted global leader in bone graft technologies, providing solutions for bone regeneration in over 50 countries. Their products are utilized across a range of medical disciplines, including orthopaedics, trauma surgery, spine, ENT, stomatology, and dental surgery.

Biomatlante collaborates closely with renowned universities and research centers worldwide, such as CNRS and INSERM, to ensure the continuous advancement of their biomaterials and surgical technologies, resulting in long-term projects and intellectual protection. Their extensive product range includes MBCP® synthetic bone substitutes, injectable bone substitutes, resorbable collagen membranes, interference screws, and surgical instrumentation. As a brand committed to driving progress in the healthcare industry, Biomatlante is dedicated to meeting and surpassing the demanding needs of today's market